These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20929907)

  • 21. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
    Findling RL; Maxwell K; Wiznitzer M
    Psychopharmacol Bull; 1997; 33(1):155-9. PubMed ID: 9133768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The autistic-spectrum disorders.
    Rapin I
    N Engl J Med; 2002 Aug; 347(5):302-3. PubMed ID: 12151466
    [No Abstract]   [Full Text] [Related]  

  • 23. Case study: risperidone in children and adolescents with schizophrenia.
    Quintana H; Keshavan M
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1292-6. PubMed ID: 7592266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.
    Zuddas A; Di Martino A; Muglia P; Cianchetti C
    J Child Adolesc Psychopharmacol; 2000; 10(2):79-90. PubMed ID: 10933118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status.
    Kalkan Ucar S; Ozbaran B; Demiral N; Yuncu Z; Erermis S; Coker M
    Brain Dev; 2010 Feb; 32(2):156-61. PubMed ID: 19217229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open trial of risperidone in young autistic children.
    Nicolson R; Awad G; Sloman L
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):372-6. PubMed ID: 9549957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
    Saxena K; Chang K; Steiner H
    Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of behavioral disorders by risperidone in children with autism].
    Wei BY; Huang F; Qin XT; Liang QQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):216-8. PubMed ID: 21426640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
    Correia CT; Almeida JP; Santos PE; Sequeira AF; Marques CE; Miguel TS; Abreu RL; Oliveira GG; Vicente AM
    Pharmacogenomics J; 2010 Oct; 10(5):418-30. PubMed ID: 19997080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study.
    Troost PW; Althaus M; Lahuis BE; Buitelaar JK; Minderaa RB; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):561-73. PubMed ID: 17069545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind pilot study of risperidone in the treatment of conduct disorder.
    Findling RL; McNamara NK; Branicky LA; Schluchter MD; Lemon E; Blumer JL
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):509-16. PubMed ID: 10761354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone in PDD.
    Fisman S; Steele M; Pipher B
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):15-6. PubMed ID: 9444894
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up.
    Perry R; Pataki C; Munoz-Silva DM; Armenteros J; Silva RR
    J Child Adolesc Psychopharmacol; 1997; 7(3):167-79. PubMed ID: 9466234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder.
    Dinnissen M; Dietrich A; van den Hoofdakker BJ; Hoekstra PJ
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):111-24. PubMed ID: 25385293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacology of autism spectrum disorders.
    Kaplan G; McCracken JT
    Pediatr Clin North Am; 2012 Feb; 59(1):175-87, xii. PubMed ID: 22284801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does risperidone improve hyperacusia in children with autism?
    Ghanizadeh A
    Psychopharmacol Bull; 2009; 42(1):108-10. PubMed ID: 19204655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world.
    Ameis SH; Corbett-Dick P; Cole L; Correll CU
    J Clin Psychiatry; 2013 Oct; 74(10):1022-4. PubMed ID: 24229756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.